These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 1884609)

  • 1. Treatment of gram-negative septic shock with an immunoglobulin preparation: a prospective, randomized clinical trial.
    Schedel I; Dreikhausen U; Nentwig B; Höckenschnieder M; Rauthmann D; Balikcioglu S; Coldewey R; Deicher H
    Crit Care Med; 1991 Sep; 19(9):1104-13. PubMed ID: 1884609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in anti-endotoxin-IgG antibody and endotoxaemia in three cases of gram-negative septic shock.
    Barclay GR; Scott BB; Wright IH; Rogers PN; Smith DG; Poxton IR
    Circ Shock; 1989 Oct; 29(2):93-106. PubMed ID: 2582583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endotoxin concentration in neutropenic patients with suspected gram-negative sepsis: correlation with clinical outcome and determination of anti-endotoxin core antibodies during therapy with polyclonal immunoglobulin M-enriched immunoglobulins.
    Behre G; Schedel I; Nentwig B; Wörmann B; Essink M; Hiddemann W
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2139-46. PubMed ID: 1444293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential anti-core glycolipid immunoglobulin antibody activities in patients with and without septic shock and their relation to outcome.
    Nys M; Damas P; Joassin L; Lamy M
    Ann Surg; 1993 Mar; 217(3):300-6. PubMed ID: 8452409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibodies to lipoid A in the treatment of septic shock].
    Jaspers L; Marget W; Mar PJ; Hoffmann K; Langecker P; Ruckdeschel G; Obermeier A; Kastenbauer E
    Infection; 1987; 15(2):146-52. PubMed ID: 3298069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating endotoxin and antiendotoxin antibodies during severe sepsis and septic shock.
    Maury E; Blanchard HS; Chauvin P; Guglielminotti J; Alzieu M; Guidet B; Offenstadt G
    J Crit Care; 2003 Jun; 18(2):115-20. PubMed ID: 12800122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial.
    Hentrich M; Fehnle K; Ostermann H; Kienast J; Cornely O; Salat C; Ubelacker R; Buchheidt D; Behre G; Hiddemann W; Schiel X
    Crit Care Med; 2006 May; 34(5):1319-25. PubMed ID: 16540956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary study on treatment of septic shock patients with antilipopolysaccharide IgG from blood donors.
    Fomsgaard A; Baek L; Fomsgaard JS; Engquist A
    Scand J Infect Dis; 1989; 21(6):697-708. PubMed ID: 2617211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of gram-negative septic shock with human IgG antibody to Escherichia coli J5: a prospective, double-blind, randomized trial.
    Calandra T; Glauser MP; Schellekens J; Verhoef J
    J Infect Dis; 1988 Aug; 158(2):312-9. PubMed ID: 3136210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lipoid A antibody titer in the human].
    Marget W
    Infection; 1987; 15(2):142-5. PubMed ID: 3596812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group.
    Greenman RL; Schein RM; Martin MA; Wenzel RP; MacIntyre NR; Emmanuel G; Chmel H; Kohler RB; McCarthy M; Plouffe J
    JAMA; 1991 Aug; 266(8):1097-102. PubMed ID: 1865542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective properties of a human IgG preparation rich in antibodies to a wide spectrum of lipopolysaccharides.
    Fomsgaard A; Galanos C
    APMIS; 1989 Dec; 97(12):1114-20. PubMed ID: 2611025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary study on administration of high-titer lipid A antibody serum in sepsis and septic shock patients.
    Marget W; Mar PJ; Jaspers L; Possinger K; Haslberger H
    Infection; 1985; 13(3):120-4. PubMed ID: 4030108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early therapy with IgM-enriched polyclonal immunoglobulin in patients with septic shock.
    Cavazzuti I; Serafini G; Busani S; Rinaldi L; Biagioni E; Buoncristiano M; Girardis M
    Intensive Care Med; 2014 Dec; 40(12):1888-96. PubMed ID: 25217146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endotoxemia in human septic shock.
    Danner RL; Elin RJ; Hosseini JM; Wesley RA; Reilly JM; Parillo JE
    Chest; 1991 Jan; 99(1):169-75. PubMed ID: 1984950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.
    Ziegler EJ; Fisher CJ; Sprung CL; Straube RC; Sadoff JC; Foulke GE; Wortel CH; Fink MP; Dellinger RP; Teng NN
    N Engl J Med; 1991 Feb; 324(7):429-36. PubMed ID: 1988827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of antibodies to endotoxin core to mortality in medical patients with sepsis syndrome.
    Strutz F; Heller G; Krasemann K; Krone B; Müller GA
    Intensive Care Med; 1999 May; 25(5):435-44. PubMed ID: 10401935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of gram-negative septic shock with an immunoglobulin preparation: a prospective, randomized clinical trial.
    Wortel CH; Dellinger RP
    Crit Care Med; 1993 Jan; 21(1):163-5. PubMed ID: 8420724
    [No Abstract]   [Full Text] [Related]  

  • 20. [Endotoxin in the clinic and in experiments].
    Rumiantsev AG; Kasatkin VN; Kanaeva ES
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (3):110-4. PubMed ID: 7941855
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.